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ORIGINAL ARTICLE
Epidermal Hyperplasia and Elevated HB-EGF are More 
Prominent in Retinoid Dermatitis Compared with 
Irritant Contact Dermatitis Induced by Benzalkonium 
Chloride
Jung Eun Lee, M.D.*, Jae Yong Chang, M.D.*, Sang Eun Lee, M.D., Moon Young Kim, M.S., 
Jeong Seon Lee, B.S., Min Geol Lee, M.D., Soo-Chan Kim, M.D.
Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
Background: ‘Retinoid dermatitis’ is a retinoid-induced 
irritant contact dermatitis (ICD). The mechanism of retinoid 
dermatitis may be different from that of other ICDs. 
However, it remains uncertain how topical retinoid induce 
ICD. Objective: We compared several aspects of contact 
dermatitis induced by topical retinol and benzalkonium 
chloride (BKC) on hairless mice skin. Methods: 2% retinol or 
2.5% BKC was applied to hairless mice and transepidermal 
water loss (TEWL), ear thickness, histologic and immuno-
histochemical findings were compared. We also compared 
mRNA expression of inflammatory cytokines, epidermal 
differential markers, cyclooxygenases (COXs) and heparin 
binding epidermal growth factor like growth factor (HB- 
EGF). Results: Topical application of 2% retinol and 2.5% 
BKC increased TEWL and ear thickness in similar intensity. 
Epidermal hyperplasia was more prominent in retinol treated 
skin. Proliferating cell nuclear antigen, involucrin and 
loricrin expression were higher in retinol-treated skin than in 
BKC-treated skin. Filaggrin, however, was more expressed in 
BKC-treated skin. The mRNA expression of IL-8, TNF-α, 
COX-2, involucrin, loricrin and filaggrin were increased in 
both retinol- and BKC-treated skin in similar intensity. 
HB-EGF was more significantly increased in retinol-treated 
skin. Conclusion: Elevated HB-EGF and epidermal hyper-
plasia are more prominent features of retinoid dermatitis 
than in BKC-induced ICD. (Ann Dermatol 22(3) 290∼299, 
2010)
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INTRODUCTION
Many patients undergoing topical retinoid therapy ex-
perience retinoid dermatitis, a retinoid-induced irritant 
contact dermatitis (ICD) characterized by erythema, scal-
ing, dryness, burning and pruritus, which in turn, result in 
discontinuation of topical retinoid treatment.
ICD is a cutaneous inflammation as a result of the direct 
cytotoxic effects of a chemical or physical agent. The 
pathophysiological pathway of ICD begins with pene-
tration of the permeability barrier, damage of keratino-
cytes followed by the release of inflammatory mediators, 
such as IL-6, IL-8 and TNF-α1,2.
Retinoid dermatitis is considered to be induced by a 
mechanism distinct from that of other irritants and peeling 
agents3,4. Even though irritation induced by retinoic acid 
(RA) is generally considered a non-specific and un-
desirable adverse effect3, retinoic acid irritancy may be 
partly related to a receptor-mediated mechanism5,6.
RA bind to retinoic acid receptors (RARs) to activate the 
heterodimeric complex (RARs/RXRs) that binds to the 
retinoic acid response elements (RARE), thereby directly 
stimulating target gene transcription7. Among RAR pro-
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teins in the epidermis, nearly 90% are RAR-γ, with 
approximately 10% of RAR-α and no detectable RAR-β7. 
Chen et al.6 reported that RAR-γ mediated retinoid 
dermatitis in animal models. However, it remains unclear 
how retinoid and retinoid receptor interaction lead to 
retinoid dermatitis.
Recently, cytokines and cyclooxygenases (COXs) are 
thought to be involved in the induction of irritation. COX 
catalyzed the conversion of arachidonic acid (AA) to 
prostaglandin (PG) and exists in 2 isoforms, COX-1 and 
COX-28. COX-1 is expressed constitutively in most tissues 
and involved primarily in cellular homeostasis, whereas 
COX-2 is highly inducible and plays a major role in 
inflammation8,9.
It has been shown that heparin-binding epidermal growth 
factor-like growth factor (HB-EGF) can be induced by 
treatment with retinoids in human keratinocytes and 
organ-cultured skin, suggesting that epidermal hyperplasia 
following RA treatment may be mediated, at least in part, 
by keratinocyte-derived HB-EGF10. Other studies con-
firmed that HB-EGF mRNA was markedly induced by 
RA in normal human keratinocytes and normal mouse 
skin11-13. Chapellier’s study also demonstrated a positive 
correlation between HB-EGF expression and RA-induced 
proliferation, further supporting the hypothesis that HB- 
EGF could be a paracrine factor synthesized in the 
suprabasal layers that mediates RA-induced hyperpla-
sia12,13. In human skin, HB-EGF and amphiregulin have 
been reported to activate epidermal growth factor receptor 
(EGFR) and mediate retinoid-induced epidermal hyper-
plasia14.
The aim of this study was to elucidate the retinoid 
dermatitis specific features compared with ICD induced 
by benzalkonium chloride (BKC). In this study, we applied 
retinol and BKC on hairless mice and compared trans-
epidermal water loss (TEWL), ear thickness, histopatho-
logic findings, immunohistochemistry of epidermal pro-
liferation and differentiation markers (proliferation cell 
nuclear antigen [PCNA], involucrin, loricrin, filaggrin). We 
also compared the mRNA expression of epidermal pro-
liferation and differentiation markers, inflammatory cyto-
kines (IL-8, TNF-α), enzymes associated with inflam-
mation (COXs) and HB-EGF with reverse transcriptase- 
polymerase chain reaction (RT-PCR).
MATERIALS AND METHODS
Animals
16 female hairless mice at the age of 6-weeks were used. 
Two groups of 8 mice were maintained at a temperature 
of 23±3oC, and a humidity of 50±10% in a controlled 
room. Throughout the study, the mice were fed on 
standard mouse pellets and water ad libtum.
Induction of irritant dermatitis
In the preliminary studies, we found 2% all-trans-retinol 
(Sigma-Aldrich, St. Louis, MO, USA) and 2.5% BKC 
(Sigma-Aldrich, St. Louis, MO, USA) induced similar 
intensity of inflammation as measured by TEWL and ear 
thickness. Thus, 2% retinol and 2.5% BKC were used to 
compare irritant reaction induced by retinol and BKC. In 
the retinol-treated group, 2% retinol in ethanol was 
applied to the left ear and left back, and ethanol alone as a 
vehicle was applied to the right ear and right back. In the 
BKC-treated group, 2.5% BKC in acetone was applied to 
the left ear and left back, and acetone was applied to the 
right ear and right back. 20μl of each test compound was 
applied once daily for 4 consecutive days.
Measurement of TEWL and mouse ear edema
TEWL was measured from the back of hairless mice with 
Tewameter (Courage＋Khazaka, Köln, Germany). The 
extent of edema induced by the skin irritants was 
measured by ear thickness with a dial thickness gauge 
(Peacock, Tokyo, Japan).
Immunohistochemistry
Paraffin sections were mounted on saline-coated micro-
scopic slides (Muto Pure Chemicals, Tokyo, Japan) and 
washed serially in xylene and 100% ethanol for de-
paraffinization and rehydration. Endogenous peroxidase 
was inactivated with 3% H2O2 for 5 min followed by 
washing in ddH2O for 5 min. All of the following 
incubations were performed in a humidity chamber. The 
sections were incubated in 10 mM of sodium citrate buffer 
(pH 6.0) and microwaved for 10 min, then cooled in a 
refrigerator for 15 min and washed serially in ddH2O and 
PBS for 5 min. The primary antibodies used were 
monoclonal mouse anti-human PCNA (DAKO, Glostrup, 
Denmark), polyclonal rabbit anti-mouse involucrin (Con-
vance Research Products, Denver, PA, USA), loricrin 
(Convance Research Products, Denver, PA, USA) and 
filaggrin (Convance Research Products, Denver, PA, USA). 
The sections were incubated with the primary antibodies 
diluted 1:100 for 1 hour at room temperature. Biotinylated 
secondary antibody with streptavidin-horseradish peroxi-
dase was applied with a CAP-PLUS kit (Zymed, San 
Francisco, CA, USA) using the LAB-SA method. The 
sections were stained with the NovaRED substrate kit 
(Vector, Burlingame, CA, USA) and counterstained with 
hematoxylin.
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Fig. 1. Transepidermal water loss (TEWL) measured from the skin
topically treated with retinol is significantly elevated than that
measured in skin treated with ethanol. TEWL measured from the
skin topically treated with benzalkonium chloride (BKC) was also
significantly elevated, compared to that measured in skin treated
with acetone. However, there was no significant difference 
between TEWL measured in retinol- and BKC-applied skin. Data
are presented as mean±SEM, *p＜0.01. Statistical significance
was determined using Student’s t test, empty box: ethanol-treated
skin, shaded box: retinol-treated skin, striped box: acetone- 
treated skin, filled box: BKC-treated skin.
Fig. 2. Ear thickness is significantly increased in both retinol-
and benzalkonium chloride (BKC)-treated ears compared to 
ethanol- and acetone-treated ears, however, there is no sig-
nificant difference between retinol- and BKC-treated ear. Data
are presented as mean±SEM, *p＜0.01. Statistical significance 
was determined using Student’s t test, empty box: ethanol-treated
skin, shaded box: retinol-treated skin, striped box: acetone- 
treated skin, filled box: BKC-treated skin.
Reverse transcriptase-PCR
Mouse ear and back skin tissue excised from each hairless 
mouse were incubated in 20 mM EDTA/PBS for 1 h at 
37oC. The epidermis was separated from the dermis with 
fine forceps. RNA was extracted from the epidermis with 
Trizol reagent (Gibco BRL, Gaitherburg, MD, USA) con-
taining acid-guanidinium thiocyanate-phenol chloroform. 
Extracted RNA was electrophoresed in formaldehyde 
denaturing gel to check 28s and 18s bands. Con-
centrations of samples were titrated arbitrarily to 1μg/ml 
using BioPhotometer (Eppendorf, Hamburg, Germany). 
RT-PCR was performed using RNA-PCR kit version 3.0 
(Takara, Otsu, Japan). Briefly, cDNA amplification 
conditions are described as follows. Cycles of denaturing 
at 94oC for 30 seconds, annealing at 60oC for 30 seconds 
and extension at 72oC for 90 seconds were repeated 35 
times. PCR products were electrophoresed in 4% Nusieve 
3:1 agarose gel (FMC, Rockland, ME, USA) and analyzed 
quantitatively using GelDoc2000 documentation system 
(Bio-Rad, Hercules, CA, USA). We utilized GAPDH and 
actin as house keeping genes. The primer sequences for 
cytokines, epidermal differentiation markers, COXs and 
HB-EGF were as follows: for IL-8 (KC), 5’-ATAACGCG-
TATGCAGCGCCTATCGCCAATGAGCTG-3’ and 5’-CCA-
GATCTTACTTGGGGACACCTTT-3’; for TNF-α, 5’-GGC-
AGGTCTA CTTTAGAGTCATTGC-3’ and 5’-ACATTCGA-
GGCTCCAGTGAATTCGG-3’; for COX-1, 5’-AGTCGCA-
GGAGTCTCTCGCTCTGG-3’ and 5’-CAGGAAATGGGT-
GAACGAGGGGCT-3’; for COX-2, 5’-TTCAAAAGAAG-
TGCTGGAAAAGGTTCT-3’ and 5’-AGATCATCTCTACC-
TGAGTGTCCTT-3’; for HB-EGF, 5’-TCCGTCTGTCTTCT-
TGTCATCGT-3’ and 5’-TAGCCACGCCCAACTTCACT-3’; 
for filaggrin, 5’-CAGGGTCAGCGCAAGATC-3’ and 5’- 
TGAGCCAGAGCTGGAACC-3’; for involucrin, 5’-CGG-
ATATGGCAGGGGATC-3’ and 5’-GGTGTAATTCTGGC-
TCACCAAG-3’; for loricrin, 5’-GGATCGTCCCAACAG-
TATCAG-3’ and 5’-GACTGGTCT GCTGAGAGGAGTA-
AT-3’; for GAPDH, 5’-AATGGTGAAGGTCGGT GTGA-3’ 
and 5’-CTGGAAGATGGTGATGGGC-3’; for actin, 5’- 
TGGAATCCTGTGGCATCCATGAAAC-3’ and 5’-TAAAA-
CGCAGCTCAGTAACAGTCCG-3’.
Statistics
When comparisons were made between 2 groups, sta-
tistical significance was determined using Student’s t-test. 
When comparisons were made between multiple groups, 
statistical significances were determined using ANOVA 
analysis.
RESULTS
Change in TEWL
TEWL in both retinol- and BKC-applied skin is markedly 
increased but there is no significant difference between 
TEWL measured in retinol- and BKC-treated skin (Fig. 1).
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Fig. 3. Both retinol and benzalkonium chloride (BKC)-induced epidermal hyperplasia and inflammation. H&E-stained sections of 
ethanol-applied mouse ear (A), retinol-treated (B), acetone-treated ear (C), BKC-treated ear (D). Both retinol and BKC treatments result 
in epidermal hyperplasia, increased intercellular edema and dermal inflammatory cell infiltration (B and D). Epidermal hyperplasia and
separation of the stratum corneum are more pronounced in retinol-applied ear skin compared to BKC-applied ear skin (H&E stain, ×400).
Fig. 4. Epidermal hyperplasia was also measured quantitatively 
by the number of keratinocyte layers in the epidermis. The 
number of keratinocyte layers is increased in both retinol- and
benzalkonium chloride (BKC)-treated ears, compared to ethanol-
and acetone-treated ears. The number of keratinocyte layers is 
significantly increased in retinol-treated skin, compared to BKC-
treated skin. Data are presented as mean±SEM, *p＜0.01. 
Statistical significance was determined using Student’s t test, 
empty box: ethanol-treated skin, shaded box: retinol-treated skin,
striped box: acetone-treated skin, filled box: BKC-treated skin.
Change in ear thickness
Ear thickness is significantly increased in both retinol- and 
BKC-treated ears compared to ethanol- and acetone- 
treated ears. There was no significant difference between 
retinol- and BKC-treated mouse ear (Fig. 2).
Histopathological findings
H&E-stained sections from alcohol or acetone applied ears 
showed normal epidermal thickness with few dermal 
inflammatory cell infiltration, but sections from retinol- or 
BKC-applied ears showed epidermal hyperplasia, in-
creased intercellular edema and dermal inflammatory cell 
infiltration. Epidermal hyperplasia and separation of the 
stratum corneum are markedly pronounced in retinol- 
applied skin, compared to BKC-applied skin (Fig. 3). 
Epidermal hyperplasia was also measured quantitatively 
by the average number of keratinocyte layers in the 
epidermis measured in three different locations in high 
power field (Fig. 4). The average number of keratinocyte 
layers is increased in both retinol- and BKC-applied ears 
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Fig. 5. Immunohistochemical stain - proliferation cell nuclear antigen (PCNA). (A) Normal epidermis, (B) Retinol, (C) Benzalkonium 
chloride (BKC). PCNA expressions in retinol- or BKC-applied skin are increased than those in normal or vehicle-applied skin. PCNA 
expression is more pronounced in retinol-applied skin than BKC-applied skin (×400).
compared to ethanol- and acetone-applied ears. The 
number of keratinocyte layers is significantly increased in 
retinol-applied skin compared to BKC-applied skin.
Immunohistochemical study findings
Immunohistochemical staining for PCNA to determine the 
extent of hyperproliferation showed that PCNA ex-
pressions in ethanol- or acetone-applied skin were normal. 
However, PCNA expressions in the basal layer of retinol- 
or BKC-applied skin were increased. The increase was 
more pronounced in retinol-applied skin (Fig. 5).
We also performed immnunohistochemical staining for 
involucrin, loricrin, and filaggrin to determine the extent 
of epidermal differentiation. There was no remarkable 
increase in the expressions of these differentiation markers 
in ethanol- or acetone-applied skin, but the expressions of 
differentiation markers, such as involucrin, loricrin, and 
filaggrin were increased in the upper spinous layer and 
granular layer of retinol- or BKC-applied skin. Marked 
increase of involucrin and moderate increase of loricrin 
were observed in retinol-applied skin, compared to 
BKC-applied skin (Fig. 6). On the contrary, filaggrin was 
more pronounced in BKC-applied skin compared to 
retinol-applied skin.
Reverse transcriptase-polymerase chain reaction results
Agarose gel electrophoresis of each cDNA associated with 
inflammation and keratinocyte growth (IL-8, TNF-α, 
COX-1, COX-2 and HB-EGF) amplified with RT-PCR is 
shown in Fig. 7A. No significant differences in COX-1 
levels between the 4 groups were observed (Fig. 7A, B). 
IL-8, TNF-α, COX-2 and HB-EGF levels were significantly 
increased in retinol- or BKC-treated skin compared to 
vehicle-treated skin (Fig. 7A, C∼F). Moreover, the 
HB-EGF level in retinol-treated skin was significantly 
increased compared to BKC-applied skin (Fig. 7A, F).
Agarose gel electrophoresis of each cDNA associated with 
keratinocytes differentiation (involucrin, loricrin and fila-
ggrin) amplified with RT-PCR is shown in Fig. 8A. In-
volucrin, loricrin and filaggrin levels were significantly 
increased in retinol- or BKC-treated skin compared to 
vehicle-treated skin (Fig. 8B∼D).
DISCUSSION
In this study, we found 2% retinol and 2.5% BKC induced 
similar level of barrier disruption and inflammation, as 
measured by TEWL and ear thickness, and we assumed 
that our model of ICD was adequate to compare different 
skin response to the application of retinol and BKC. As 
representative inflammatory mediators, we measured the 
profiles of inflammatory cytokines (IL-8, TNF-α) and 
COXs.
While resting keratinocytes produce some cytokines 
constitutively, a variety of environmental stimuli, such as 
tumor promoters, ultraviolet light and chemical agents can 
induce epidermal keratinocytes to release inflammatory 
cytokines (IL-1, TNF-α), chemotactic cytokines (IL-8, IP- 
10), growth promoting cytokines (IL-6, IL-7, IL-15, GM- 
CSF, TGF-α) and cytokines regulating immunity (IL-10, 
IL-12, IL-18). Many studies have been conducted to 
determine cytokine mRNA expression profiles in in vitro 
and in vivo ICD models2. Pro-inflammatory cytokine TNF-
α15,16 and chemotactic cytokine IL-82,17 were up-regulated 
in ICD models in previous in vivo and in vitro studies, 
although most of the studies were performed in the early 
induction stage of irritant dermatitis. TNF-α and IL-8 were 
also reported to be up-regulated in retinoid dermatitis18-20. 
In our study, we observed that TNF-α and IL-8 up- 
regulation in both retinol- and BKC-induced dermatitis 
were consistent with that reported previously. There 
were no statistically significant differences in the levels of 
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Fig. 6. Immunohistochemical stain - involucrin, loricrin, filaggrin. (A, D, G) Normal epidermis, (B) Involucrin in retinol, (C) Involucrin
in benzalkonium chloride (BKC), (E) Loricrin in retinol, (F) Loricrin in BKC, (H) Filaggrin in retinol, (I) Filaggrin in BKC. Involucrin
expressions in retinol- or BKC-treated skin are increased. Involucrin expression is slightly pronounced in retinol-treated skin, compared
to BKC-treated skin. Loricrin expressions in retinol- or BKC-treated skin are increased. Loricrin expression is markedly pronounced
in retinol-treated skin compared to BKC-treated skin Filaggrin expressions in retinol- or BKC-treated skin are increased. Filaggrin 
expression is slightly pronounced in BKC-treated skin compared to retinol-treated skin (×400).
TNF-α and IL-8 up-regulation between retinol- and BKC- 
induced dermatitis.
The effect of retinoids on COXs is variable in different cell 
types. Xiao et al.21 reported that COX-2 protein expression 
was significantly increased by 9-cis retinoic acid, while 
COX-1 expression was not altered in scleroderma fib-
roblasts. On the other hand, in human skin squamous 
carcinoma cells which express COX-2 protein consti-
tutively, 9-cis retinoic acid suppressed COX-2 expression 
and cell growth22. In our study, we observed no significant 
changes of COX-1 in retinol- or BKC-induced dermatitis, 
compared to ethanol- or acetone-treated controls, but we 
did observe a significant increase in COX-2 levels in both 
retinol- and BKC-induced dermatitis. There was no dif-
ference of COX-2 expression levels between retinol- and 
BKC-induced dermatitis.
Whereas the effects of retinoids on keratinocyte growth 
in cultures are variable, retinoids consistently stimulate 
keratinocyte growth in vivo7. Chapellier et al.12 de-
monstrated that topical retinoid signal was transduced by 
RXRα/RARγ heterodimers in suprabasal keratinocytes, 
which, in turn, stimulate the proliferation of basal 
keratinocytes via a paracrine signal that could be a 
heparin-binding EGF-like growth factor. Interestingly, 
HB-EGF does not possess any putative RARE. Therefore, 
direct modulation of HB-EGF by RARE promoters appears 
unlikely. Rather, RAR/RXR is likely to regulating other 
transcription factor that would, in turn, regulate HB-EGF 
gene expression23. Even though it is well known that 
irritants such as BKC induce epidermal hyperplasia, the 
underlying mechanism has not been thoroughly inves-
tigated as that in retinoids24,25. Scrape wounding, phorbol 
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Fig. 7. (A) Agarose gel electrophoresis of each cDNA amplified with reverse transcriptase-polymerase chain reaction (RT-PCR) (IL-8, 
TNF-α, COX-1, COX-2 and HB-EGF). (B) COX-1 levels by RT-PCR between 4 groups. No significant difference in COX-1 level between 
the 4 groups was observed (p=0.997, ANOVA). (C) IL-8 levels by RT-PCR between the 4 groups. IL-8 in retinol- or benzalkonium 
chloride (BKC)-applied skin is significantly increased compared to ethanol- or acetone-treated skin, respectively (p=0.012, p=0.006). 
However, no significant difference in IL-8 level between retinol- and BKC-treated groups was observed (p=0.157). (D) TNF-α levels 
by RT-PCR between the 4 groups. TNF-α in retinol- or BKC-treated skin is significantly increased compared to ethanol- or 
acetone-treated skin, respectively (p=0.001, p=0.046). No significant difference in TNF-α level between retinol- and BKC-treated 
groups was observed (p=0.460). (E) COX-2 levels by RT-PCR between the 4 groups. Unlike COX-1 results, COX-2 in retinol- or 
BKC-applied skin is significantly increased compared to ethanol- or acetone-treated skin, respectively (p＜0.0001, p=0.005). No 
significant difference in COX-2 level between retinol- and BKC-treated groups was observed (p=0.221). (F) HB-EGF levels by RT-PCR 
between the four groups. HB-EGF in retinol- or BKC-treated skin is significantly increased compared to ethanol- or acetone-treated 
skin, respectively (p=0.01, p=0.0017). Moreover, HB-EGF in retinol-applied skin was significantly increased compared to BKC-treated 
skin (p=0.029). Data are presented as mean±SEM, *p＜0.05, †p＜0.01. Statistical significance was determined using Student’s t-test, 
empty box: ethanol-treated skin, shaded box: retinol-treated skin, striped box: acetone-treated skin, filled box: BKC-treated skin.
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Fig. 8. (A) Agarose gel electrophoresis of each cDNA amplified with reverse transcriptase-polymerase chain reaction (RT-PCR) (involucrin,
loricrin, and filaggrin). (B) Involucrin in retinol- or benzalkonium chloride (BKC)-treated skin is significantly increased compared to
ethanol- or acetone-treated skin respectively (p=0.017, p=0.020). However, no significant difference in involucrin level between
retinol- and BKC-treated groups was observed. (C) Loricrin in retinol- or BKC-treated skin is significantly increased compared to ethanol-
or acetone-treated skin, respectively (p=0.025, p=0.0007). However, no significant difference in loricrin level between retinol- and
BKC-treated groups was observed. (D) Filaggrin in retinol- or BKC-treated skin is significantly increased compared to ethanol- or 
acetone-treated skin, respectively (p=0.001, p=0.001). However, no significant difference in filaggrin level between retinol- and 
BKC-treated groups was observed. Data are presented as mean±SEM, *p＜0.05, †p＜0.01. Statistical significance was determined
using Student’s t test, empty box: ethanol-applied skin, shaded box: retinol-applied skin, striped box: acetone-applied skin, filled box:
BKC-applied skin.
ester and various other stress stimuli on cultured cells are 
able to induce HB-EGF mRNA levels and the shedding of 
proHB-EGF into soluble HB-EGF26. In addition to EGF, 
IL-8 is also active as a mitogen for epithelial and 
endothelial cell proliferation26.
In our study, we observed a significant increase of 
HB-EGF expression in retinol-treated skin and in BKC- 
treated skin. Interestingly, expression of HB-EGF in 
retinol-treated skin was significantly increased than that in 
BKC-treated skin. This result is also consistent with 
markedly pronounced epidermal hyperplasia in retinol- 
induced ICD compared to BKC-induced ICD in our 
histopathological findings, and markedly increased ex-
pression of PCNA in our immunohistochemistry results. 
These results suggest that elevated HB-EGF and epidermal 
hyperplasia are more prominent, and the distinguished 
features of retinoid dermatitis although other ICD also 
showed elevated HB-EGF and epidermal hyperplasia. 
Abnormal proliferation of keratinocytes leading to pro-
nounced epidermal hyperplasia and subsequent abnormal 
differentiation of the epidermis may lead to disruption of 
barrier function and inflammation in retinoid dermatitis.
Epithelial differentiation markers, including profilaggrin, 
loricrin, cornifin (small proline rich proteins), and trans-
glutaminase 1 are also negatively regulated by retinoids in 
vitro27-30. On the contrary, retinoids up-regulate kera-
tinocyte terminal differentiation markers in vivo31,32. 
Similarly, mild irritation by detergent, sodium dodecyl 
sulfate induced rapid and strong expression of the 
cornified envelope precursor protein involucrin in the 
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stratum spinosum33. In our study, involucrin, loricrin and 
filaggrin levels were significantly increased in retinol- or 
BKC-applied skin compared to vehicle-applied skin as 
measured by RT-PCR and immunohistochemical stains.
The mechanism of retinoid dermatitis involves barrier 
disruption, cytokines, COX and HB-EGF induced epi-
dermal hyperplasia. Although most of the factors men-
tioned above are also involved in ICD induced by BKC, 
relatively higher expression of HB-EGF and epidermal 
hyperplasia in retinoid dermatitis may be the characteristic 
features of retinoid dermatitis. Therefore, epidermal hy-
perplasia and elevated HB-EGF could be recognized as 
retinoid dermatitis specific feature. However, the un-
derlying mechanism of retinoid dermatitis should be 
investigated in further.
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